Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-021843

Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-27 Exercise or conversion : show line 1 in the form +20,000 $2.01 $40,200 330,815 D
2018-03-27 Sale : show line 2 in the form −20,000 $8.00 $160,000 310,815 D
Open-market sales · 20,000 sh · avg $8.00 · $160,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-27 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −20,000 322,000 D
Loading xslF345X03/doc4.xml…